Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open-label, crossover trial

Jens Christian Laursen; Victor Robain Curovic; Marjolein Y.A.M. Kroonen; Niels Jongs; Emiel H. Zobel; Tine W. Hansen; Marie Frimodt-Moller; Gozewijn D. Laverman; Adriaan Kooy; Frederik Persson; Hiddo J.L. Heerspink; Christiaan Stevns Hansen; Peter Rossing

doi:10.1111/dom.15180

Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open-label, crossover trial

Jens Christian Laursen^*
, Victor Robain Curovic
, Marjolein Y.A.M. Kroonen
, Niels Jongs
, Emiel H. Zobel
, Tine W. Hansen
, Marie Frimodt-Moller
, Gozewijn D. Laverman
, Adriaan Kooy
, Frederik Persson
, Hiddo J.L. Heerspink
, Christiaan Stevns Hansen
, Peter Rossing

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	3064-3067
Number of pages	4
Journal	Diabetes, Obesity and Metabolism
Volume	25
Issue number	10
Early online date	29 Jun 2023
DOIs	https://doi.org/10.1111/dom.15180
Publication status	Published - Oct 2023
Externally published	Yes

Keywords

SGLT2 inhibitor
Clinical trial
Diabetes complications
Diabetic neuropathy
Empagliflozin
Linagliptin
n/a OA procedure

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/dom.15180

Cite this

Laursen, J. C., Curovic, V. R., Kroonen, M. Y. A. M., Jongs, N., Zobel, E. H., Hansen, T. W., Frimodt-Moller, M., Laverman, G. D., Kooy, A., Persson, F., Heerspink, H. J. L., Hansen, C. S., & Rossing, P. (2023). Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open-label, crossover trial. Diabetes, Obesity and Metabolism, 25(10), 3064-3067. https://doi.org/10.1111/dom.15180

@article{00530a13e24b4f7c802e1449fabd8616,

title = "Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open-label, crossover trial",

keywords = "SGLT2 inhibitor, Clinical trial, Diabetes complications, Diabetic neuropathy, Empagliflozin, Linagliptin, n/a OA procedure",

author = "Laursen, \{Jens Christian\} and Curovic, \{Victor Robain\} and Kroonen, \{Marjolein Y.A.M.\} and Niels Jongs and Zobel, \{Emiel H.\} and Hansen, \{Tine W.\} and Marie Frimodt-Moller and Laverman, \{Gozewijn D.\} and Adriaan Kooy and Frederik Persson and Heerspink, \{Hiddo J.L.\} and Hansen, \{Christiaan Stevns\} and Peter Rossing",

year = "2023",

month = oct,

doi = "10.1111/dom.15180",

language = "English",

volume = "25",

pages = "3064--3067",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "Wiley",

number = "10",

}

Laursen, JC, Curovic, VR, Kroonen, MYAM, Jongs, N, Zobel, EH, Hansen, TW, Frimodt-Moller, M, Laverman, GD, Kooy, A, Persson, F, Heerspink, HJL, Hansen, CS & Rossing, P 2023, 'Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open-label, crossover trial', Diabetes, Obesity and Metabolism, vol. 25, no. 10, pp. 3064-3067. https://doi.org/10.1111/dom.15180

Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open-label, crossover trial. / Laursen, Jens Christian; Curovic, Victor Robain; Kroonen, Marjolein Y.A.M. et al.
In: Diabetes, Obesity and Metabolism, Vol. 25, No. 10, 10.2023, p. 3064-3067.

Research output: Contribution to journal › Letter › Academic › peer-review

TY - JOUR

T1 - Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes

T2 - An exploratory, randomized, open-label, crossover trial

AU - Laursen, Jens Christian

AU - Curovic, Victor Robain

AU - Kroonen, Marjolein Y.A.M.

AU - Jongs, Niels

AU - Zobel, Emiel H.

AU - Hansen, Tine W.

AU - Frimodt-Moller, Marie

AU - Laverman, Gozewijn D.

AU - Kooy, Adriaan

AU - Persson, Frederik

AU - Heerspink, Hiddo J.L.

AU - Hansen, Christiaan Stevns

AU - Rossing, Peter

PY - 2023/10

Y1 - 2023/10

KW - SGLT2 inhibitor

KW - Clinical trial

KW - Diabetes complications

KW - Diabetic neuropathy

KW - Empagliflozin

KW - Linagliptin

KW - n/a OA procedure

U2 - 10.1111/dom.15180

DO - 10.1111/dom.15180

M3 - Letter

C2 - 37385968

SN - 1462-8902

VL - 25

SP - 3064

EP - 3067

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

IS - 10

ER -